Please login to the form below

Not currently logged in
Email:
Password:

Research Partnership

This page shows the latest Research Partnership news and features for those working in and with pharma, biotech and healthcare.

Boehringer bolsters NASH pipeline with $201m Dicerna deal

Boehringer bolsters NASH pipeline with $201m Dicerna deal

Our research team is diligently working to discover effective new therapies for NASH and other chronic liver diseases, which is a priority area for us, ”commented Boehringer’s head of discovery ... This partnership complements our existing research

Latest news

  • IMI aims €130m at medical research's unanswered questions IMI aims €130m at medical research's unanswered questions

    IMI aims 130m at medical research's unanswered questions. Targets for the partnership’s latest funding round including Alzheimer’s. ... As these new call topics show, there are still many challenges and unanswered questions in medical research and

  • Untreatable gonorrhoea on the march worldwide, says WHO Untreatable gonorrhoea on the march worldwide, says WHO

    Following behind is zoliflodacin from Entasis Therapeutics, which completed a phase II trial and has just been partnered with the not-for-profit Global Antibiotic Research and Development Partnership (GARDP), paving ... moves in some countries, notably

  • Research Partnership expands across America Research Partnership expands across America

    Research Partnership expands across America. Firm opens new offices in San Francisco and New York. ... Mary Assimakopoulos, founding director of Research Partnership, said: “Research Partnership is celebrating its 20.

  • Ashley Communications celebrates 20 years of medical communications Ashley Communications celebrates 20 years of medical communications

    We also believe our partnership with Southwood research, which was announced earlier this year, has contributed to our success by providing a truly combined service that really adds value to the

  • Takeda launches drug discovery biotech Takeda launches drug discovery biotech

    Tri-I TDI currently has 50 early-stage research drug discovery projects underway and these will also benefit from Bridge Medicines' financial, operational and managerial support. ... The collaboration between Takeda and the Tri-I TDI enables funding of

More from news
Approximately 2 fully matching, plus 111 partially matching documents found.

Latest Intelligence

  • Immuno-oncology's evolution: implications for pharma market researche Immuno-oncology's evolution: implications for pharma market researche

    On November 17 Research Partnership, in association with PMGroup, will host a free webinar which will explore the key features of the immuno-oncology market and the critical success factors for ... How this will impact your market research needs.

  • Biosimilars - the same, but different? Biosimilars - the same, but different?

    Laurent Chanroux, research director at Research Partnership who leads the company's autoimmune real-world data portfolio with access to more than 175, 000 biologic patient records, sees some interesting market ... Certainly when it comes to early

  • The evolving biosimilars market The evolving biosimilars market

    Although these key regulatory developments are expected to greatly facilitate the approval of biosimilars in the near future, recent research from Research Partnership's Therapy Watch revealed that only 47% of

  • Can we do more? Can we do more?

    Research conducted in partnership with The Behavioural Architects .

  • Communicating in a crisis Communicating in a crisis

    J&J announces it will fast-track vaccine research. October 2014. EMA offers orphan drug benefits to Ebola drugs. ... Pharma firms are involved in several ways, including the development of new drugs and vaccines, with GSK, J&J and Merck all fast-tracked

More from intelligence
Approximately 1 fully matching, plus 11 partially matching documents found.

Latest appointments

  • Pfizer’s Elizabeth Barrett joins Novartis as its oncology head Pfizer’s Elizabeth Barrett joins Novartis as its oncology head

    She has been instrumental in creating new commercial models, driving innovation in close partnership with research and development and leveraging business development opportunities.

  • Research Partnership appoints new directors Research Partnership appoints new directors

    Research Partnership appoints new directors. Anne Cunningham and Morten Anderson join the UK-based group. ... Mark Jeffery, founding director at Research Partnership, said: “We are delighted to welcome both Anne and Morten to Research Partnership.

  • Helen Parfitt joins Research Partnership Helen Parfitt joins Research Partnership

    Helen Parfitt joins Research Partnership. She takes on role as head of its Therapy Watch market tracking tool. ... Research Partnership has appointed Helen Parfitt as its new director, head of Therapy Watch - a ‘real-time’syndicated global market

  • Research Partnership appoints Tom Nolte Research Partnership appoints Tom Nolte

    Research Partnership appoints Tom Nolte. He takes up a role as director and head of business analytics, North America. ... London-based healthcare research and consulting firm the Research Partnership has appointed Tom Nolte as director and head of

  • Research Partnership appoints graphic designer to head office team Research Partnership appoints graphic designer to head office team

    Research Partnership appoints graphic designer to head office team. Amanda Brent will create 'storytelling solutions' for the agency. ... Research Partnership has appointed Amanda Brent as a multi-media graphic designer based in the company's London head

More from appointments
Approximately 10 fully matching, plus 7 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 6 fully matching, plus 23 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics